A pilot study to assess the safety of dobutamine stress echocardiography in the emergency department evaluation of cocaine-associated chest pain
Study Objective: Chest pain in the setting of cocaine use poses a diagnostic dilemma. Dobutamine stress echocardiography (DSE) is a widely available and sensitive test for evaluating cardiac ischemia. Because of the theoretical concern regarding administration of dobutamine in the setting of cocaine...
Gespeichert in:
Veröffentlicht in: | Annals of emergency medicine 2001-07, Vol.38 (1), p.42-48 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 48 |
---|---|
container_issue | 1 |
container_start_page | 42 |
container_title | Annals of emergency medicine |
container_volume | 38 |
creator | Dribben, William H. Kirk, Mark A. Trippi, James A. Cordell, William H. |
description | Study Objective: Chest pain in the setting of cocaine use poses a diagnostic dilemma. Dobutamine stress echocardiography (DSE) is a widely available and sensitive test for evaluating cardiac ischemia. Because of the theoretical concern regarding administration of dobutamine in the setting of cocaine use, we conducted a pilot study to assess the safety of DSE in emergency department patients with cocaine-associated chest pain. Methods: A prospective case series was conducted in the intensive diagnostic and treatment unit in the ED of an urban tertiary-care teaching hospital. Patients were eligible for DSE if they had used cocaine within 24 hours preceding the onset of chest pain and had a normal ECG and tropinin I level. Patients exhibiting signs of continuing cocaine toxicity were excluded from the study. All patients were admitted to the hospital for serial testing after the DSE testing in the intensive diagnostic and treatment unit. Results: Twenty-four patients were enrolled. Two patients had inadequate resting images, one DSE was terminated because of inferior hypokinesis, another DSE was terminated because of a rate-related atrial conduction deficit, and 1 patient did not reach the target heart rate. Thus, 19 patients completed a DSE and reached their target heart rates. None of the patients experienced signs of exaggerated adrenergic response, which was defined as a systolic blood pressure of greater than 200 mm Hg or the occurrence of tachydysrhythmias (excluding sinus tachycardia). Further suggesting lack of exaggerated adrenergic response, 13 (65%) of 20 patients required supplemental atropine to reach their target heart rates. Conclusion: No exaggerated adrenergic response was detected when dobutamine was administered to patients with cocaine-related chest pain. [Dribben WH, Kirk MA, Trippi JA, Cordell WH. A pilot study to assess the safety of dobutamine stress echocardiography in the emergency department evaluation of cocaine-associated chest pain. Ann Emerg Med. July 2001;38:42-48.] |
doi_str_mv | 10.1067/mem.2001.115623 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1067_mem_2001_115623</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S019606440118176X</els_id><sourcerecordid>11423811</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-708169a2a71ca842c7cbaac8f3b584d95d8b32c1ebcd3ae75bf7a05768ba880f3</originalsourceid><addsrcrecordid>eNp1kE1P3DAQhi3UChbaM7fKh16z2M6HnSNCQJFW6qU9R5PxhDXaxJHtRcq_6E_Gy64El54sjZ_39fhh7FqKtRSNvhlpXCsh5FrKulHlGVtJ0eqi0Y34wlZCtk0hmqq6YJcxvggh2krJc3YhZaVKI-WK_bvls9v5xGPa24UnzyFGipGnLfEIA6WF-4Fb3-8TjG7KwxQO94RbjxCs888B5u3C3fSeoZHCM024cEszhDTSlDi9wm4PyfnpUIY5mJuK_JJHB4ksxy3FxOc8_sa-DrCL9P10XrG_D_d_7n4Vm9-PT3e3mwJLrVKhhZFNCwq0RDCVQo09AJqh7GtT2ba2pi8VSurRlkC67gcNotaN6cEYMZRX7ObYi8HHGGjo5uBGCEsnRXdw22W33cFtd3SbEz-OiXnfj2Q_-JPMDPw8ARARdkOACV381FuXRumMtUeM8vdeHYUuosvGyLpAmDrr3X93eAN9w5kZ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A pilot study to assess the safety of dobutamine stress echocardiography in the emergency department evaluation of cocaine-associated chest pain</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Dribben, William H. ; Kirk, Mark A. ; Trippi, James A. ; Cordell, William H.</creator><creatorcontrib>Dribben, William H. ; Kirk, Mark A. ; Trippi, James A. ; Cordell, William H.</creatorcontrib><description>Study Objective: Chest pain in the setting of cocaine use poses a diagnostic dilemma. Dobutamine stress echocardiography (DSE) is a widely available and sensitive test for evaluating cardiac ischemia. Because of the theoretical concern regarding administration of dobutamine in the setting of cocaine use, we conducted a pilot study to assess the safety of DSE in emergency department patients with cocaine-associated chest pain. Methods: A prospective case series was conducted in the intensive diagnostic and treatment unit in the ED of an urban tertiary-care teaching hospital. Patients were eligible for DSE if they had used cocaine within 24 hours preceding the onset of chest pain and had a normal ECG and tropinin I level. Patients exhibiting signs of continuing cocaine toxicity were excluded from the study. All patients were admitted to the hospital for serial testing after the DSE testing in the intensive diagnostic and treatment unit. Results: Twenty-four patients were enrolled. Two patients had inadequate resting images, one DSE was terminated because of inferior hypokinesis, another DSE was terminated because of a rate-related atrial conduction deficit, and 1 patient did not reach the target heart rate. Thus, 19 patients completed a DSE and reached their target heart rates. None of the patients experienced signs of exaggerated adrenergic response, which was defined as a systolic blood pressure of greater than 200 mm Hg or the occurrence of tachydysrhythmias (excluding sinus tachycardia). Further suggesting lack of exaggerated adrenergic response, 13 (65%) of 20 patients required supplemental atropine to reach their target heart rates. Conclusion: No exaggerated adrenergic response was detected when dobutamine was administered to patients with cocaine-related chest pain. [Dribben WH, Kirk MA, Trippi JA, Cordell WH. A pilot study to assess the safety of dobutamine stress echocardiography in the emergency department evaluation of cocaine-associated chest pain. Ann Emerg Med. July 2001;38:42-48.]</description><identifier>ISSN: 0196-0644</identifier><identifier>EISSN: 1097-6760</identifier><identifier>DOI: 10.1067/mem.2001.115623</identifier><identifier>PMID: 11423811</identifier><identifier>CODEN: AEMED3</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Adult ; Biological and medical sciences ; Cardiotonic Agents - adverse effects ; Chest Pain - chemically induced ; Chest Pain - diagnostic imaging ; Chest Pain - physiopathology ; Cocaine-Related Disorders - complications ; Diagnosis, Differential ; Dobutamine - adverse effects ; Drug toxicity and drugs side effects treatment ; Echocardiography - methods ; Echocardiography - standards ; Electrocardiography ; Emergency Treatment - methods ; Emergency Treatment - standards ; Exercise Test - methods ; Exercise Test - standards ; Heart Rate - drug effects ; Humans ; Hypertension - chemically induced ; Medical sciences ; Middle Aged ; Myocardial Ischemia - chemically induced ; Myocardial Ischemia - diagnostic imaging ; Myocardial Ischemia - physiopathology ; Pharmacology. Drug treatments ; Pilot Projects ; Prospective Studies ; Safety ; Sympathomimetics - adverse effects ; Tachycardia - chemically induced ; Toxicity: cardiovascular system</subject><ispartof>Annals of emergency medicine, 2001-07, Vol.38 (1), p.42-48</ispartof><rights>2001 American College of Emergency Physicians.</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-708169a2a71ca842c7cbaac8f3b584d95d8b32c1ebcd3ae75bf7a05768ba880f3</citedby><cites>FETCH-LOGICAL-c372t-708169a2a71ca842c7cbaac8f3b584d95d8b32c1ebcd3ae75bf7a05768ba880f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1067/mem.2001.115623$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1053827$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11423811$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dribben, William H.</creatorcontrib><creatorcontrib>Kirk, Mark A.</creatorcontrib><creatorcontrib>Trippi, James A.</creatorcontrib><creatorcontrib>Cordell, William H.</creatorcontrib><title>A pilot study to assess the safety of dobutamine stress echocardiography in the emergency department evaluation of cocaine-associated chest pain</title><title>Annals of emergency medicine</title><addtitle>Ann Emerg Med</addtitle><description>Study Objective: Chest pain in the setting of cocaine use poses a diagnostic dilemma. Dobutamine stress echocardiography (DSE) is a widely available and sensitive test for evaluating cardiac ischemia. Because of the theoretical concern regarding administration of dobutamine in the setting of cocaine use, we conducted a pilot study to assess the safety of DSE in emergency department patients with cocaine-associated chest pain. Methods: A prospective case series was conducted in the intensive diagnostic and treatment unit in the ED of an urban tertiary-care teaching hospital. Patients were eligible for DSE if they had used cocaine within 24 hours preceding the onset of chest pain and had a normal ECG and tropinin I level. Patients exhibiting signs of continuing cocaine toxicity were excluded from the study. All patients were admitted to the hospital for serial testing after the DSE testing in the intensive diagnostic and treatment unit. Results: Twenty-four patients were enrolled. Two patients had inadequate resting images, one DSE was terminated because of inferior hypokinesis, another DSE was terminated because of a rate-related atrial conduction deficit, and 1 patient did not reach the target heart rate. Thus, 19 patients completed a DSE and reached their target heart rates. None of the patients experienced signs of exaggerated adrenergic response, which was defined as a systolic blood pressure of greater than 200 mm Hg or the occurrence of tachydysrhythmias (excluding sinus tachycardia). Further suggesting lack of exaggerated adrenergic response, 13 (65%) of 20 patients required supplemental atropine to reach their target heart rates. Conclusion: No exaggerated adrenergic response was detected when dobutamine was administered to patients with cocaine-related chest pain. [Dribben WH, Kirk MA, Trippi JA, Cordell WH. A pilot study to assess the safety of dobutamine stress echocardiography in the emergency department evaluation of cocaine-associated chest pain. Ann Emerg Med. July 2001;38:42-48.]</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Cardiotonic Agents - adverse effects</subject><subject>Chest Pain - chemically induced</subject><subject>Chest Pain - diagnostic imaging</subject><subject>Chest Pain - physiopathology</subject><subject>Cocaine-Related Disorders - complications</subject><subject>Diagnosis, Differential</subject><subject>Dobutamine - adverse effects</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Echocardiography - methods</subject><subject>Echocardiography - standards</subject><subject>Electrocardiography</subject><subject>Emergency Treatment - methods</subject><subject>Emergency Treatment - standards</subject><subject>Exercise Test - methods</subject><subject>Exercise Test - standards</subject><subject>Heart Rate - drug effects</subject><subject>Humans</subject><subject>Hypertension - chemically induced</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myocardial Ischemia - chemically induced</subject><subject>Myocardial Ischemia - diagnostic imaging</subject><subject>Myocardial Ischemia - physiopathology</subject><subject>Pharmacology. Drug treatments</subject><subject>Pilot Projects</subject><subject>Prospective Studies</subject><subject>Safety</subject><subject>Sympathomimetics - adverse effects</subject><subject>Tachycardia - chemically induced</subject><subject>Toxicity: cardiovascular system</subject><issn>0196-0644</issn><issn>1097-6760</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1P3DAQhi3UChbaM7fKh16z2M6HnSNCQJFW6qU9R5PxhDXaxJHtRcq_6E_Gy64El54sjZ_39fhh7FqKtRSNvhlpXCsh5FrKulHlGVtJ0eqi0Y34wlZCtk0hmqq6YJcxvggh2krJc3YhZaVKI-WK_bvls9v5xGPa24UnzyFGipGnLfEIA6WF-4Fb3-8TjG7KwxQO94RbjxCs888B5u3C3fSeoZHCM024cEszhDTSlDi9wm4PyfnpUIY5mJuK_JJHB4ksxy3FxOc8_sa-DrCL9P10XrG_D_d_7n4Vm9-PT3e3mwJLrVKhhZFNCwq0RDCVQo09AJqh7GtT2ba2pi8VSurRlkC67gcNotaN6cEYMZRX7ObYi8HHGGjo5uBGCEsnRXdw22W33cFtd3SbEz-OiXnfj2Q_-JPMDPw8ARARdkOACV381FuXRumMtUeM8vdeHYUuosvGyLpAmDrr3X93eAN9w5kZ</recordid><startdate>20010701</startdate><enddate>20010701</enddate><creator>Dribben, William H.</creator><creator>Kirk, Mark A.</creator><creator>Trippi, James A.</creator><creator>Cordell, William H.</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20010701</creationdate><title>A pilot study to assess the safety of dobutamine stress echocardiography in the emergency department evaluation of cocaine-associated chest pain</title><author>Dribben, William H. ; Kirk, Mark A. ; Trippi, James A. ; Cordell, William H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-708169a2a71ca842c7cbaac8f3b584d95d8b32c1ebcd3ae75bf7a05768ba880f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Cardiotonic Agents - adverse effects</topic><topic>Chest Pain - chemically induced</topic><topic>Chest Pain - diagnostic imaging</topic><topic>Chest Pain - physiopathology</topic><topic>Cocaine-Related Disorders - complications</topic><topic>Diagnosis, Differential</topic><topic>Dobutamine - adverse effects</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Echocardiography - methods</topic><topic>Echocardiography - standards</topic><topic>Electrocardiography</topic><topic>Emergency Treatment - methods</topic><topic>Emergency Treatment - standards</topic><topic>Exercise Test - methods</topic><topic>Exercise Test - standards</topic><topic>Heart Rate - drug effects</topic><topic>Humans</topic><topic>Hypertension - chemically induced</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myocardial Ischemia - chemically induced</topic><topic>Myocardial Ischemia - diagnostic imaging</topic><topic>Myocardial Ischemia - physiopathology</topic><topic>Pharmacology. Drug treatments</topic><topic>Pilot Projects</topic><topic>Prospective Studies</topic><topic>Safety</topic><topic>Sympathomimetics - adverse effects</topic><topic>Tachycardia - chemically induced</topic><topic>Toxicity: cardiovascular system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dribben, William H.</creatorcontrib><creatorcontrib>Kirk, Mark A.</creatorcontrib><creatorcontrib>Trippi, James A.</creatorcontrib><creatorcontrib>Cordell, William H.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Annals of emergency medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dribben, William H.</au><au>Kirk, Mark A.</au><au>Trippi, James A.</au><au>Cordell, William H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A pilot study to assess the safety of dobutamine stress echocardiography in the emergency department evaluation of cocaine-associated chest pain</atitle><jtitle>Annals of emergency medicine</jtitle><addtitle>Ann Emerg Med</addtitle><date>2001-07-01</date><risdate>2001</risdate><volume>38</volume><issue>1</issue><spage>42</spage><epage>48</epage><pages>42-48</pages><issn>0196-0644</issn><eissn>1097-6760</eissn><coden>AEMED3</coden><abstract>Study Objective: Chest pain in the setting of cocaine use poses a diagnostic dilemma. Dobutamine stress echocardiography (DSE) is a widely available and sensitive test for evaluating cardiac ischemia. Because of the theoretical concern regarding administration of dobutamine in the setting of cocaine use, we conducted a pilot study to assess the safety of DSE in emergency department patients with cocaine-associated chest pain. Methods: A prospective case series was conducted in the intensive diagnostic and treatment unit in the ED of an urban tertiary-care teaching hospital. Patients were eligible for DSE if they had used cocaine within 24 hours preceding the onset of chest pain and had a normal ECG and tropinin I level. Patients exhibiting signs of continuing cocaine toxicity were excluded from the study. All patients were admitted to the hospital for serial testing after the DSE testing in the intensive diagnostic and treatment unit. Results: Twenty-four patients were enrolled. Two patients had inadequate resting images, one DSE was terminated because of inferior hypokinesis, another DSE was terminated because of a rate-related atrial conduction deficit, and 1 patient did not reach the target heart rate. Thus, 19 patients completed a DSE and reached their target heart rates. None of the patients experienced signs of exaggerated adrenergic response, which was defined as a systolic blood pressure of greater than 200 mm Hg or the occurrence of tachydysrhythmias (excluding sinus tachycardia). Further suggesting lack of exaggerated adrenergic response, 13 (65%) of 20 patients required supplemental atropine to reach their target heart rates. Conclusion: No exaggerated adrenergic response was detected when dobutamine was administered to patients with cocaine-related chest pain. [Dribben WH, Kirk MA, Trippi JA, Cordell WH. A pilot study to assess the safety of dobutamine stress echocardiography in the emergency department evaluation of cocaine-associated chest pain. Ann Emerg Med. July 2001;38:42-48.]</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>11423811</pmid><doi>10.1067/mem.2001.115623</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0196-0644 |
ispartof | Annals of emergency medicine, 2001-07, Vol.38 (1), p.42-48 |
issn | 0196-0644 1097-6760 |
language | eng |
recordid | cdi_crossref_primary_10_1067_mem_2001_115623 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adult Biological and medical sciences Cardiotonic Agents - adverse effects Chest Pain - chemically induced Chest Pain - diagnostic imaging Chest Pain - physiopathology Cocaine-Related Disorders - complications Diagnosis, Differential Dobutamine - adverse effects Drug toxicity and drugs side effects treatment Echocardiography - methods Echocardiography - standards Electrocardiography Emergency Treatment - methods Emergency Treatment - standards Exercise Test - methods Exercise Test - standards Heart Rate - drug effects Humans Hypertension - chemically induced Medical sciences Middle Aged Myocardial Ischemia - chemically induced Myocardial Ischemia - diagnostic imaging Myocardial Ischemia - physiopathology Pharmacology. Drug treatments Pilot Projects Prospective Studies Safety Sympathomimetics - adverse effects Tachycardia - chemically induced Toxicity: cardiovascular system |
title | A pilot study to assess the safety of dobutamine stress echocardiography in the emergency department evaluation of cocaine-associated chest pain |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T13%3A31%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20pilot%20study%20to%20assess%20the%20safety%20of%20dobutamine%20stress%20echocardiography%20in%20the%20emergency%20department%20evaluation%20of%20cocaine-associated%20chest%20pain&rft.jtitle=Annals%20of%20emergency%20medicine&rft.au=Dribben,%20William%20H.&rft.date=2001-07-01&rft.volume=38&rft.issue=1&rft.spage=42&rft.epage=48&rft.pages=42-48&rft.issn=0196-0644&rft.eissn=1097-6760&rft.coden=AEMED3&rft_id=info:doi/10.1067/mem.2001.115623&rft_dat=%3Cpubmed_cross%3E11423811%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/11423811&rft_els_id=S019606440118176X&rfr_iscdi=true |